Baxter International (NYSE:BAX) Moves On Piper Jaffray Initiation. How Much Are Shares Worth?

May 18, 2018 - By Robert Crowder

Baxter International Inc. (NYSE:BAX) Logo

Investors sentiment is 0.97 in 2017 Q4. Its the same as in 2017Q3. It is without change, as 32 investors sold Baxter International Inc. shares while 311 reduced holdings. only 81 funds opened positions while 250 raised stakes. 441.20 million shares or 0.32% more from 439.80 million shares in 2017Q3 were reported.

Nichols & Pratt Advisers Llp Ma stated it has 5,040 shares. Moreover, Winfield has 0.02% invested in Baxter International Inc. (NYSE:BAX) for 616 shares. Dearborn Limited Company owns 0.03% invested in Baxter International Inc. (NYSE:BAX) for 6,544 shares. Jefferies Grp Inc holds 0.03% in Baxter International Inc. (NYSE:BAX) or 94,642 shares. Weatherly Asset Management Limited Partnership reported 0.43% of its portfolio in Baxter International Inc. (NYSE:BAX). Oregon Public Employees Retirement Fund holds 121,096 shares or 0.12% of its portfolio. Brown Advisory has invested 0.02% in Baxter International Inc. (NYSE:BAX). Bp Plc holds 56,000 shares or 0.13% of its portfolio. State Of Alaska Department Of Revenue, a Alaska-based fund reported 84,820 shares. Geode Capital Mgmt Ltd Co has 5.81 million shares. Bankshares Of Ny Mellon Corporation invested in 4.93 million shares or 0.08% of the stock. Verition Fund Mngmt Lc, Connecticut-based fund reported 15,042 shares. Holderness Investments invested in 5,120 shares. Nomura Holding has invested 0.01% in Baxter International Inc. (NYSE:BAX). Boston Family Office Limited Liability Company reported 0.06% in Baxter International Inc. (NYSE:BAX).

Since March 2, 2018, it had 0 insider buys, and 5 sales for $5.13 million activity. Another trade for 18,750 shares valued at $1.21 million was sold by GAVIN JAMES R III. The insider HELLMAN PETER S sold $243,408. The insider Shapazian Carole J sold $329,590. STORM KORNELIS J. also sold $3.10 million worth of Baxter International Inc. (NYSE:BAX) shares.

Why Has Piper Jaffray Given Baxter International (NYSE:BAX) a $77.0000 Price Target

Equity research analysts at Piper Jaffray started coverage on Baxter International (NYSE:BAX) with a key Buy rating. The PT for BAX is $77.0000. It would indicate a possible upside of 8.99 % from company’s last close price.

Baxter International Inc. (NYSE:BAX) Ratings Coverage

Among 12 analysts covering Baxter International (NYSE:BAX), 7 have Buy rating, 0 Sell and 5 Hold. Therefore 58% are positive. Baxter International has $80.0 highest and $66.0 lowest target. $74.88’s average target is 5.99% above currents $70.65 stock price. Baxter International had 17 analyst reports since November 22, 2017 according to SRatingsIntel. As per Tuesday, January 2, the company rating was upgraded by Bank of America. The firm has “Hold” rating by Stifel Nicolaus given on Monday, February 5. The firm has “Overweight” rating given on Friday, February 2 by Barclays Capital. The stock of Baxter International Inc. (NYSE:BAX) earned “Buy” rating by BMO Capital Markets on Tuesday, December 12. The company was maintained on Monday, April 30 by Stifel Nicolaus. The firm has “Hold” rating given on Thursday, February 1 by Cowen & Co. Deutsche Bank upgraded the shares of BAX in report on Tuesday, February 20 to “Buy” rating. The stock has “Neutral” rating by Citigroup on Tuesday, February 6. The firm earned “Hold” rating on Thursday, February 1 by RBC Capital Markets. The stock of Baxter International Inc. (NYSE:BAX) earned “Hold” rating by RBC Capital Markets on Wednesday, November 22.

The stock decreased 0.13% or $0.09 during the last trading session, reaching $70.65. About 2.71 million shares traded. Baxter International Inc. (NYSE:BAX) has risen 25.16% since May 18, 2017 and is uptrending. It has outperformed by 13.61% the S&P500.

Analysts await Baxter International Inc. (NYSE:BAX) to report earnings on July, 25. They expect $0.71 earnings per share, up 12.70 % or $0.08 from last year’s $0.63 per share. BAX’s profit will be $380.19M for 24.88 P/E if the $0.71 EPS becomes a reality. After $0.70 actual earnings per share reported by Baxter International Inc. for the previous quarter, Wall Street now forecasts 1.43 % EPS growth.

Baxter International Inc. provides a portfolio of renal and hospital products. The company has market cap of $37.83 billion. The firm operates through two divisions, Hospital Products and Renal. It has a 54.9 P/E ratio. The Hospital Products segment makes intravenous solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics, and biosurgery products.

More notable recent Baxter International Inc. (NYSE:BAX) news were published by: 247Wallst.com which released: “Top Analyst Upgrades and Downgrades: AIG, Baxter, Cisco, Eiger Bio, Energy Transfer, Juniper, NOV, Phillips 66 …” on May 17, 2018, also Seekingalpha.com with their article: “Premarket analyst action – healthcare” published on May 17, 2018, Seekingalpha.com published: “Baxter Is Quickly Rebuilding Its Solid Dividend” on May 17, 2018. More interesting news about Baxter International Inc. (NYSE:BAX) were released by: Streetinsider.com and their article: “Piper Jaffray Assumes Baxter International (BAX) at Overweight” published on May 17, 2018 as well as Streetinsider.com‘s news article titled: “Baxter (BAX) Announces US FDA Clearance of New Spectrum IQ Infusion System” with publication date: May 14, 2018.

Baxter International Inc. (NYSE:BAX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: